I posted a column at the Marketing Health Blog about some of the ways that the FDA's first social media guidance is helping industry overcome the regulatory challenges of participating in real-time dialogue.
Take a look and let me know what you think.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.